Media

October 20, 2025
BoB In South Florida: Anthony Japour, M.D., iTolerance

January 6, 2023
Type 1 Diabetes: A Potential Cure

November 3, 2022
New Startup Develops Potential Cure for Type 1 Diabetes

November 1, 2022
Companies To Watch: iTolerance

May 21, 2022
A New Option For Type 1 Diabetes Treatment Shows Promising Pre-Clinical Results.

May 20, 2022
Research Roundup: New Hope for T1 Diabetes Pancreatic Cell Transplant.

May 17, 2022
A New Technique Can Revolutionize the Treatment of Type 1 Diabetes.

May 17, 2022
Preclinical Study Demonstrates Long-term Success of Allogeneic Islet Implantation for Diabetes.

May 17, 2022
Altering the Body’s Immune System to Treat Type 1 Diabetes.

May 16, 2022
iTolerance, Inc. Pre-Clinical Non-Human Primate Study Demonstrates Long-Term Success of Allogeneic Islet Implantation Without Chronic Immunosuppression for the Treatment of Diabetes.

May 16,2022
Biomaterial Prevents Rejection of Islet Grafts for Diabetes Therapy.

May 15, 2022
New Trial Brings Hopeful Treatment One Step Closer To The Clinic.

May 15, 2022
Novel Biomaterial Prevents Rejection Of Transplants For Type 1 Diabetes: Clinical Trial Is Planned Based On Results From Preclinical Study.

May 15, 2022
Microgel Beads Offer Safer Path for Cell Transplants to Treat Diabetes.

May 13, 2022
Researchers Closing in on Possible Diabetes Breakthrough.  

May 13, 2022
Biomaterial Improves Islet Transplants for Treatment of Type 1 Diabetes.

May 13, 2022
Modifying the Body’s Immune System to Help Treat Type 1 Diabetes.

May 13, 2022
Novel Approach Allows Islet Transplants to Survive and Control Diabetes.

May 13, 2022
MU, Harvard and Georgia Tech Develop Novel Type 1 Diabetes Treatment.

May 13, 2022
Protein Gel Could Help Treat Type 1 Diabetes.

May 13, 2022
Biomaterial Improves Islet Transplants for Treatment of Type 1 Diabetes.